138 related articles for article (PubMed ID: 38598827)
1. MRI and biopsy in prostate cancer are the hot topic in this number of International Brazilian Journal of Urology.
Favorito LA
Int Braz J Urol; 2024; 50(3):234-236. PubMed ID: 38598827
[No Abstract] [Full Text] [Related]
2. [Paradigm shift in urology : Prostate cancer diagnosis using MRI-targeted or standard transrectal ultrasonography-guided biopsy].
Hadaschik B
Urologe A; 2018 Jun; 57(6):727-728. PubMed ID: 29740666
[No Abstract] [Full Text] [Related]
3. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
Zattoni F; Marra G; Kasivisvanathan V; Grummet J; Nandurkar R; Ploussard G; Olivier J; Chiu PK; Valerio M; Gontero P; Guo H; Zhuang J; Barletta F; Leni R; Frydenberg M; Moon D; Hanegbi U; Landaumailto A; Snow R; Apfelbeck M; Kretschmer A; van den Bergh R; Novara G; Briganti A; Dal Moro F; Gandaglia G
J Urol; 2022 Oct; 208(4):830-837. PubMed ID: 36082555
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
[TBL] [Abstract][Full Text] [Related]
5. MRI-TRUS fusion targeted biopsy is highligheted in International Brazilian Journal of Urology.
Favorito LA
Int Braz J Urol; 2023; 49(3):278-280. PubMed ID: 37115174
[No Abstract] [Full Text] [Related]
6. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
[TBL] [Abstract][Full Text] [Related]
7. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study.
Zattoni F; Marra G; Martini A; Kasivisvanathan V; Grummet J; Harkin T; Ploussard G; Olivier J; Chiu PK; Valerio M; Marquis A; Gontero P; Guo H; Zhuang J; Frydenberg M; Moon D; Morlacco A; Kretschmer A; Barletta F; Heidegger I; Tilki D; van den Bergh R; Dal Moro F; Briganti A; Montorsi F; Novara G; Gandaglia G;
Eur Urol Focus; 2023 Jul; 9(4):621-628. PubMed ID: 36746729
[TBL] [Abstract][Full Text] [Related]
8. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Magnetic Resonance Imaging-directed Biopsy Strategies for Changing the Paradigm of Prostate Cancer Diagnosis.
Schoots IG; Padhani AR; Rouvière O; Barentsz JO; Richenberg J
Eur Urol Oncol; 2020 Feb; 3(1):32-41. PubMed ID: 31706946
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
Venderink W; Bomers JG; Overduin CG; Padhani AR; de Lauw GR; Sedelaar MJ; Barentsz JO
Eur Urol; 2020 Apr; 77(4):481-490. PubMed ID: 31791623
[TBL] [Abstract][Full Text] [Related]
11. The role of urology and radiology in prostate biopsy: current trends and future perspectives.
Mac Curtain BM; Temperley HC; Kelly JAO; Ryan J; Qian W; O'Sullivan N; Breen KJ; Mc Carthy CJ; Brennan I; Davis NF
World J Urol; 2024 Apr; 42(1):249. PubMed ID: 38649544
[TBL] [Abstract][Full Text] [Related]
12. Molecular research in urology 2014: update on PET/MR imaging of the prostate.
Wetter A
Int J Mol Sci; 2014 Jul; 15(8):13401-5. PubMed ID: 25089874
[TBL] [Abstract][Full Text] [Related]
13. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.
Drost FH; Osses D; Nieboer D; Bangma CH; Steyerberg EW; Roobol MJ; Schoots IG
Eur Urol; 2020 Jan; 77(1):78-94. PubMed ID: 31326219
[TBL] [Abstract][Full Text] [Related]
14. Standardized Magnetic Resonance Imaging Reporting Using the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation Criteria and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion with Transperineal Saturation Biopsy to Select Men on Active Surveillance.
Dieffenbacher S; Nyarangi-Dix J; Giganti F; Bonekamp D; Kesch C; Müller-Wolf MB; Schütz V; Gasch C; Hatiboglu G; Hauffe M; Stenzinger A; Duensing S; Schlemmer HP; Moore CM; Hohenfellner M; Radtke JP
Eur Urol Focus; 2021 Jan; 7(1):102-110. PubMed ID: 30878348
[TBL] [Abstract][Full Text] [Related]
15. Prostate imaging reporting and data system correlation with Gleason score: Pathological aspects of magnetic resonance imaging findings.
Yokoo P; de Oliveira Salvador GL; Castillo JJAQ; Basso ACN; Amaral RSD; de Campos ROP; Barreto RAY; Orozco OFG; Cavalli AC; Zaparolli M
Urologia; 2019 Nov; 86(4):189-196. PubMed ID: 31303145
[TBL] [Abstract][Full Text] [Related]
16. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.
Kasivisvanathan V; Rannikko AS; Borghi M; Panebianco V; Mynderse LA; Vaarala MH; Briganti A; Budäus L; Hellawell G; Hindley RG; Roobol MJ; Eggener S; Ghei M; Villers A; Bladou F; Villeirs GM; Virdi J; Boxler S; Robert G; Singh PB; Venderink W; Hadaschik BA; Ruffion A; Hu JC; Margolis D; Crouzet S; Klotz L; Taneja SS; Pinto P; Gill I; Allen C; Giganti F; Freeman A; Morris S; Punwani S; Williams NR; Brew-Graves C; Deeks J; Takwoingi Y; Emberton M; Moore CM;
N Engl J Med; 2018 May; 378(19):1767-1777. PubMed ID: 29552975
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
18. [Multi-parametric MRI/US fusion guided biopsy for the diagnosis of prostate cancer. ur experience].
Glybochko PV; Alyaev YG; Amosov AV; Enikeev DV; Chinenov DV; Krupinov GE; Puzakov KB; Koshkarev AV; Lerner YV; Petrovskii NV; Dzhalaev ZK; Chernov YN
Urologiia; 2018 Jul; (3):98-104. PubMed ID: 30035427
[TBL] [Abstract][Full Text] [Related]
19. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Moore CM; Kasivisvanathan V; Eggener S; Emberton M; Fütterer JJ; Gill IS; Grubb Iii RL; Hadaschik B; Klotz L; Margolis DJ; Marks LS; Melamed J; Oto A; Palmer SL; Pinto P; Puech P; Punwani S; Rosenkrantz AB; Schoots IG; Simon R; Taneja SS; Turkbey B; Ukimura O; van der Meulen J; Villers A; Watanabe Y;
Eur Urol; 2013 Oct; 64(4):544-52. PubMed ID: 23537686
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
